Close Menu
Libya Update NewsLibya Update News
  • Home
  • National
  • Region & World
    • The Maghreb
    • Middle East
  • Business
    • Oil & Gas
    • Economy
    • Analysis
  • Opinion
  • Editors’ Picks
  • Health & Lifestyle
  • Sports
Facebook X (Twitter) RSS
Trending
  • Ghana Assistant Coach After Loss in Benghazi: Libya Is Not an Easy Opponent and We Do Not Fear Them
  • Health Ministry Continues Implementation of Pharmaceutical Factory Inspectors Training Program as Part of Plan to Qualify 300 Inspectors
  • Recommendations to Develop the Medical Education System, Specialized Training, and Enhance Physician Competency in Libya
  • Libyan Government Signals Possible Activation of Administrative and Financial Independence After Disruption of House of Representatives Session in Zintan
  • Benghazi Medical Center denies reports of its closure next month
  • Emmaus US Expands in Libya Through Pharmaceutical Distribution Partnership
  • MP Souad Al-Shalli Selected as Jury Member for the 2026 “Inspiring Woman” Award in Libya
  • Al-Brega: Gas carriers Derna and Al-Tahadi boost supplies as congestion begins to ease
  • About Us
  • Contact Us
Facebook X (Twitter) RSS
Libya Update NewsLibya Update News
Subscribe
Wednesday, 18 November 2026
  • Home
  • National
  • Region & World
    • The Maghreb
    • Middle East
  • Business
    • Oil & Gas
    • Economy
    • Analysis
  • Opinion
  • Editors’ Picks
  • Health & Lifestyle
  • Sports
Libya Update NewsLibya Update News
Home » New Oral Diabetes Drug Lowers Blood Sugar and Helps With Weight Loss

New Oral Diabetes Drug Lowers Blood Sugar and Helps With Weight Loss

Tuesday, June 9, 2026 Health & Lifestyle 2 Mins Read
New Oral Diabetes Drug Lowers Blood Sugar and Helps With Weight Loss

Washington – Results from an international clinical trial show that a new oral drug for type 2 diabetes effectively lowers blood sugar levels and leads to significant weight loss. The drug could provide patients with an easier alternative to injectable treatments.

Researchers, led by Mass General Brigham in the United States, said the new medication may expand options for people with type 2 diabetes. The study was published in The Lancet.

Type 2 diabetes is one of the most common chronic diseases. It occurs when the body cannot use insulin properly or does not produce enough, leading to high blood sugar and increased risks of complications such as heart, kidney, nerve, and eye problems.

The researchers tested a new drug called licoglifron, an oral medication still in development. It belongs to the class of GLP-1 receptor agonists, which includes several drugs already used to treat diabetes and obesity.

Licoglifron mimics the effect of the natural GLP-1 hormone by stimulating insulin release when blood sugar rises. It also reduces production of glucagon, the hormone that raises blood sugar, slows stomach emptying, and increases feelings of fullness. These effects help control weight and improve blood sugar management.

The trial included 406 people with type 2 diabetes in nine countries. Participants were randomly assigned to receive different doses of the drug or a placebo.

After 26 weeks of treatment, up to 72.3% of those taking the drug lost at least 5% of their body weight, compared to just 20.2% in the placebo group. The drug also improved blood sugar control. Up to 89.6% of those who took licoglifron achieved an HbA1c level below 7%—the recommended target for most diabetes patients—while only 24.9% of the placebo group reached this goal.

Researchers highlighted that the drug is taken as a pill, unlike most GLP-1 therapies that require injections. This could make treatment easier for patients in the future.

Follow on Google News Follow on Facebook Follow on X (Twitter)
Share. Facebook Twitter Pinterest LinkedIn Email Reddit Telegram WhatsApp Copy Link
Previous ArticleCommission Participates in Regional Meeting on Electoral Volunteer Work in Tunisia
Next Article Ministry of Youth Opens Registration for Youth Voice and Initiative-Making Forum

Keep Reading

Health Ministry Continues Implementation of Pharmaceutical Factory Inspectors Training Program as Part of Plan to Qualify 300 Inspectors

Recommendations to Develop the Medical Education System, Specialized Training, and Enhance Physician Competency in Libya

Center for Disease Control Announces State of Alert: No Ebola Cases in Libya, Warnings Issued for Travelers as Outbreak Spreads

Libyan Media Foundation Awareness Seminar Stresses Importance of Early Detection of Breast Cancer

Parliamentary Health Committee Reviews Performance of Clinics Contracted with Health Insurance Fund

Benghazi Eye Hospital Performs More Than 15 Free Surgeries to Treat Glaucoma

Follow us on Twitter

The Libya Update Verified account Follow

Stay ahead of the curve with The #Libya Update - your go-to source for news and insights on Libyan politics, business, culture, and more. #LibyaNews

TheLibyaUpdate
thelibyaupdate

The Libya Update

Verified account @thelibyaupdate ·
17 Nov

Health Ministry Continues Implementation of Pharmaceutical Factory Inspectors Training Program as Part of Plan to Qualify 300 Inspectors

Reply on Twitter 2122690716531138849 Retweet on Twitter 2122690716531138849 Like on Twitter 2122690716531138849 Twitter 2122690716531138849
thelibyaupdate

The Libya Update

Verified account @thelibyaupdate ·
17 Nov

Recommendations to Develop the Medical Education System, Specialized Training, and Enhance Physician Competency in Libya

Reply on Twitter 2122627187279081655 Retweet on Twitter 2122627187279081655 Like on Twitter 2122627187279081655 Twitter 2122627187279081655
thelibyaupdate

The Libya Update

Verified account @thelibyaupdate ·
17 Nov

Libyan Government Signals Possible Activation of Administrative and Financial Independence After Disruption of House of Representatives Session in Zintan

Reply on Twitter 2122561382042292340 Retweet on Twitter 2122561382042292340 Like on Twitter 2122561382042292340 Twitter 2122561382042292340
libya update
Facebook X (Twitter) RSS

News

  • National News
  • The Maghreb News
  • Middle East News
  • Business News
  • Sports News

Company

  • Information
  • Ethics Policy
  • Corrections Policy
  • Fact-Checking Policy
  • GDPR Policy

Categories

  • Editors’ Picks
  • Opinion
  • Health & Lifestyle
  • Videos
  • Infographics

Subscribe to Updates




    © 2026 All copyrights reserved. The Libya Update.
    • About Us
    • Privacy Policy
    • Advertising

    Type above and press Enter to search. Press Esc to cancel.